Cargando…

Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?

The MET signaling pathway plays an important role in normal physiology and its deregulation has proved critical for development of numerous solid tumors. Different technologies have been used to investigate the genomic and proteomic status of MET in cancer patients and its association with disease p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ariyawutyakorn, Witthawat, Saichaemchan, Siriwimon, Varella-Garcia, Marileila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829549/ https://www.ncbi.nlm.nih.gov/pubmed/27076844 http://dx.doi.org/10.7150/jca.12663

Ejemplares similares

A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia–Cachexia Syndrome in Solid Cancer Patients
por: Chaiworramukkul, Aornchuma, et al.
Publicado: (2022)

ARe we there yet? Understanding androgen receptor signaling in breast cancer
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Adrenergic signaling regulation of macrophage function: do we understand it yet?
por: Freire, Beatriz Marton, et al.
Publicado: (2022)

A Pilot Study of Using Smartphone Application vs. Routine Follow-Up for Patient Care in Advanced Non-Small Cell Lung Cancer During the COVID-19 Pandemic Era
por: Prasongsook, Naiyarat, et al.
Publicado: (2022)

The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Sainamthip, Panot, et al.
Publicado: (2022)

Understanding Hyperlactatemia in Sepsis: Are We There Yet?
por: Nalos, Marek, et al.
Publicado: (2019)

Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia)
por: Thambamroong, Tawasapon, et al.
Publicado: (2022)

Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay
por: Varella-Garcia, Marileila
Publicado: (2006)

Cancer immunotherapy: are we there yet?
por: Li, Zihai, et al.
Publicado: (2013)

Safe Nanoparticles: Are We There Yet?
por: Najahi-Missaoui, Wided, et al.
Publicado: (2020)

Impact of interprofessional collaborative practice in palliative care on outcomes for advanced cancer inpatients in a resource-limited setting
por: Pornrattanakavee, Pitchayapa, et al.
Publicado: (2022)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
por: Khalafi, Shayan, et al.
Publicado: (2020)

Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques
por: Bellini, Marilanda Ferreira, et al.
Publicado: (2010)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Humanized mice: are we there yet?
por: Macchiarini, Francesca, et al.
Publicado: (2005)

Robotics and ophthalmology: Are we there yet?
por: Pandey, Suresh K, et al.
Publicado: (2019)

Prion propagation in vitro: are we there yet?
por: Ryou, Chongsuk, et al.
Publicado: (2008)

Immunometabolism in Obese Asthmatics: Are We There Yet?
por: Periyalil, Hashim A., et al.
Publicado: (2013)

Better understanding of childhood asthma, towards primary prevention – are we there yet? Consideration of pertinent literature
por: Gur, Michal, et al.
Publicado: (2017)

Treat-to-Target in Axial Spondyloarthritis: Are we there yet?
por: Aouad, Krystel, et al.
Publicado: (2022)

Clinical Transplantation and Tolerance: Are We There Yet?
por: Saidi, R. F., et al.
Publicado: (2014)

Clinical applications for exosomes: Are we there yet?
por: Perocheau, Dany, et al.
Publicado: (2021)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Transferring the critically ill patient: are we there yet?
por: Droogh, Joep M, et al.
Publicado: (2015)

Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
por: Griñan-Lison, Carmen, et al.
Publicado: (2021)

Biomarkers in renal cell carcinoma: Are we there yet?
por: Gulati, Shuchi, et al.
Publicado: (2021)

Vaccines against Drug Abuse—Are We There Yet?
por: Bloom, Benedict T., et al.
Publicado: (2022)

Treating patients with geographic atrophy: are we there yet?
por: Antonio-Aguirre, Bani, et al.
Publicado: (2023)

Detecting and Targeting Inflammation in Genetic Cardiomyopathies: Are We There Yet?
por: Pinney, Sean P., et al.
Publicado: (2023)

Deep learning models in genomics; are we there yet?
por: Koumakis, Lefteris
Publicado: (2020)

Describing a landscape we are yet discovering
por: Contreras, Sebastian, et al.
Publicado: (2022)

No vaccine against HIV yet-are we not perfectly equipped?
por: Singh, Mahender
Publicado: (2006)

Biobanking of Exosomes in the Era of Precision Medicine: Are We There Yet?
por: Mora, Edna M., et al.
Publicado: (2015)

The quest for mammalian Polycomb response elements: are we there yet?
por: Bauer, Moritz, et al.
Publicado: (2015)

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
por: Verbelen, M, et al.
Publicado: (2017)

Atrial Fibrillation Specific Exercise Rehabilitation: Are We There Yet?
por: Buckley, Benjamin J. R., et al.
Publicado: (2022)

Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?
por: Arrigo, Elisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i3m41k77nkdaeotgb79da7e1b9